Pioglitazone for Secondary Prevention after Ischemic Stroke and Transient Ischemic Attack: Rationale and Design of the Insulin Resistance Intervention after Stroke (IRIS) Trial

BACKGROUND: Recurrent vascular events remain a major source of morbidity and mortality after stroke or transient ischemic attack (TIA). The Insulin Resistance Intervention after Stroke (IRIS) trial is evaluating an approach to secondary prevention based on the established association between insulin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Heart J
Main Authors: Viscoli, Catherine M., Brass, Lawrence M., Carolei, Antonio, Conwit, Robin, Ford, Gary A., Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Lovejoy, Anne M., Parsons, Mark W., Peduzzi, Peter N., Ringleb, Peter, Schwartz, Gregory G., Spence, J. David, Tanne, David, Young, Lawrence H., Kernan, Walter N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254508/
https://ncbi.nlm.nih.gov/pubmed/25458644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2014.07.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados